13.07.2015 Views

Guidelines and Handbook for IBSCs - Department of Biotechnology

Guidelines and Handbook for IBSCs - Department of Biotechnology

Guidelines and Handbook for IBSCs - Department of Biotechnology

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Check List <strong>for</strong> <strong>IBSCs</strong>categorized with four groups based on the infectivity potential (pathogenicity)<strong>for</strong> humans out <strong>of</strong> which the first group is that <strong>of</strong> non-pathogens (Table 3).This categorization is generally applicable only <strong>for</strong> the assessment <strong>of</strong> containmentrequirements as greater containment is required to control the organismin the higher hazard groups to ensure that the organism does not infect thoseworking with it.Table 3: Categorization <strong>of</strong> microorganisms based on pathogenicityHazard Group 1Hazard Group 2Hazard Group 3Hazard Group 4Organisms that are most unlikely to cause human diseaseOrganisms capable <strong>of</strong> causing human disease <strong>and</strong> which may be ahazard to laboratory workers, but are unlikely to spread to theother co-workers <strong>of</strong> sister laboratories or community. Laboratoryexposure rarely produces obvious infection or severe diseasesymptoms <strong>and</strong> effective prophylaxis or effective treatment isusually availableOrganisms that cause severe human disease <strong>and</strong> present a serioushazard to laboratory workers. They may present a risk <strong>of</strong> spreadto the community, but there is usually effective prophylaxis ortreatment availableOrganisms that cause severe human disease <strong>and</strong> are a serioushazard to laboratory workers. They may present a high risk <strong>of</strong>spread to the community, <strong>and</strong> there is usually no effectiveprophylaxis or treatment except quarantine measures.The details <strong>of</strong> microorganisms falling into each category are given in theRecombinant DNA Safety <strong>Guidelines</strong>, 1990.Some organisms have been frequently used in rDNA technology experiments<strong>and</strong> their characteristics have been described in detail e.g. E. coli or Saccharomycescerevisae, about which a great deal is known. Further, no pathogenic strains <strong>of</strong>bakers' or brewers' yeast have ever been observed. This type <strong>of</strong> familiarity allowssome confidence in attempting to identify risks associated with their modification.Some strains, <strong>for</strong> example, E. coli K12 has been disabled to remove some <strong>of</strong> thefactors that might be associated with pathogenicity (wild type E. coli is a HazardGroup 2 pathogen). The factors which have been lost include the cell-surface K<strong>Guidelines</strong> <strong>and</strong> H<strong>and</strong>book <strong>for</strong> Institutional Biosafety Committees (<strong>IBSCs</strong>) 27

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!